Study Suggests FTY720 May Repair MS Damage By Direct Effect On Brain
FTY720 (fingolimod), an oral sphingosine-1-phosphate receptor agonist being developed for multiple sclerosis (MS), acts directly on the central nervous system (CNS) to reduce disease severity in addition to peripheral effects on the immune system, according to results from a model of the disease repo [click link for full article]
Recent Comments